TEVA – Teva Pharmaceutical Industries Ltd. – The Israel-based manufacturer of generic and branded drugs attracted bullish options investors during the trading session. Teva’s shares increased as much as 2.70% in morning trading to touch an intraday high of $53.18. Call buyers dominated trading activity and exchanged more than 5.9 calls on the stock for each single put option in play thus far today. Investors picked up 2,800 now in-the-money calls at the September $52.5 strike for an average premium of $0.78 each. Traders long the calls are poised to profit should Teva’s shares exceed the average breakeven price of $53.28 by expiration. Bullish sentiment spread to the higher September $55 strike where approximately 5,100 calls were picked up for an average premium of $0.21 each. The drug manufacturer’s shares must increase 3.8% over today’s high of $53.18 in order for September $55 strike call buyers to start to accumulate profits above the average breakeven point of $55.21. Finally, uber-bulls bought roughly 1,300 calls at the September $60 strike for premium of $0.05 a-pop. Traders holding these contracts make money if TEVA shares jump 12.9% to trade above the effective breakeven price of $60.05 by September expiration. The firm’s overall reading of options implied volatility climbed 8.5% to 23.51% by 1:00 pm ET.